← Return to Clinical trial (third line treatment) lurbinectedin and irinotecan

Discussion

Clinical trial (third line treatment) lurbinectedin and irinotecan

Pancreatic Cancer | Last Active: Jun 27, 2023 | Replies (29)
Comment receiving replies
@ro0891

My dad has a neuro tumoe. KRASG12D CHECK2
There are some being developed. I have my dad on a wait list for the MRTX1133 Drug. It is being offered at several different hospitals around the country. Problem is - it is in early stages and they're conducting the trial on 3 people at a time right now (from my understand).

Here is the link
https://www.google.com/search?q=mrtx1133&rlz=1C5CHFA_enUS853US853&oq=mrt&aqs=chrome.1.69i57j69i59j0i433i512j0i512l2j69i61l2j69i65.2426j0j4&sourceid=chrome&ie=UTF-8

Jump to this post

Replies to "My dad has a neuro tumoe. KRASG12D CHECK2 There are some being developed. I have my..."
k13 | @k13 | Jun 19, 2023

@ro0891 Thanks for the info. I know you're not a dr or a gene specialist, but would you happen to know if this drug might be applicable (it it works in trials) for all KRAS gene mutations? My husband has the KRAS G12V gene mutation. ALso- do you know which hospitals are offering this? (My husband is at Dana Farber, Boston. ) I"ll check w his dr. I don't recall seeing this trial last time I checked their website, but will check again.

VIEW AND REPLY